Eli Lilly (LLY): 3 Reasons We Love This Stock [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
The company has also beaten the index over the past six months as its stock price is up 14.5% thanks to its solid quarterly results. Is it too late to buy LLY? Find out in our full research report, it's free Why Are We Positive On LLY? Founded in 1876 by a Civil War veteran and pharmacist frustrated with the poor quality of medicines, Eli Lilly (NYSE:LLY) discovers, develops, and manufactures pharmaceutical products for conditions including diabetes, obesity, cancer, immunological disorders, and neurological diseases. 1. Skyrocketing Revenue Shows Strong Momentum Examining a company's long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, Eli Lilly grew its sales at an excellent 21.6% compounded annual growth rate. Its growth surpassed the average healthcare company and shows its offerings resonate with customers. Eli Lilly Quarterly Reven
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisition [Yahoo! Finance]Yahoo! Finance
- Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? [Yahoo! Finance]Yahoo! Finance
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies [TheStreet.com]TheStreet.com
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapiesPR Newswire
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- 3/20/26 - Form DEF
- LLY's page on the SEC website